Along with a multitude of signaling pathways, mechanisms to regulate overstimulation of receptors, broadly referred to as GPCR desensitization or equivalently known as drug tolerance as a longer term consequence, are at work across the entire GPCR super-family
Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
Care must be taken with regard to using these supplements, for the reasons noted below
Some nations allow peptides that are restricted elsewhere
Unfortunately, many chemosensory studies lack these controls as researchers are anthropomorphizing that all individuals randomly selected and then tested will respond in the same way without evidencing this using previous studies
LaRosa Dr
